Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 8, 1999 - Issue 3
Submit an article Journal homepage
158
Views
35
CrossRef citations to date
0
Altmetric
Review

The HepatAssist® Bioartificial Liver Support System: clinical study and pig hepatocyte process

Claudy Mullon Circe Biomedical, Inc., 99 Hayden Avenue, Lexington, MA 02421-7995, USA. [email protected]
&
Zorina Pitkin Circe Biomedical, Inc., 99 Hayden Avenue, Lexington, MA 02421-7995, USA. [email protected]
Pages 229-235 | Published online: 23 Feb 2005

Bibliography

  • LEE W: Acute liver failure. New Engl. J. Med. (1993)329:1862–1872.
  • PLEVRIS JN, SCHINA M, HAYES PC: The management ofacute liver failure. Aliment. Pharmacol. Ther. (1998) 12:405–418.
  • SAMUEL D: La transplantation hépatique orthotopiquepour hépatite fulminante et subfulminante. La Lettre de L 'Hépato-Gastroentérologue (1998) 2:85–89.
  • HUGHES RD, WILLIAMS R: Use of sorbent columns andhaemoffitration in fulminant hepatic failure. Blood Pu-ri! (1993) 11:163–169.
  • MCLAUGHLIN BE, TOSONE CM, CUSTER LM, MULLON C: Overview of extracorporeal liver support systems and clinical results. Ann. New York Acad. Sci. (In Press).
  • WATANABE FD, MULLON C, HEWITT WR et al.: Clinical experience with a bioartificial liver (BAL) in the treat-ment of severe liver failure: a Phase I clinical trial. Ann. Surg. (1997) 225(5):484–494.
  • WATANABE F, SHACKLETON CR, COHEN SM eta].: Treat-ment of acetaminophen-induced fulminant hepatic failure with a bioartificial liver. Transpl. Proc. (1997) 29:487–488.
  • JAUREGUI H, MULLON C, SOLOMON B: Extracorporeal Artificial Liver Support. In: Principles of Tissue Engineer-ing Lanza R, Chick W, Langer R (Eds.), Springer Co., Austin, Texas, USA (1996) 30:463–479.
  • Infectious diseases issues in xenotransplantation [draft guidelines]. US Federal Register (1996) 61:185.
  • MORSIANI E, ROZGA J, SCOTT HC et al: Automated liver cell processing facilitates large-scale isolation and pu-rification of porcine hepatocytes. ASAIO J. (1995) 41: 155–161.
  • CAIN S, NAIK S, DEANE D et al.: Large scale cryopreser-vation of porcine hepatocytes for the clinical treat-ment of acute liver failure. Cell Transpl. (1996) 5 (5S-2):19.
  • CAIN SP, CHANDLER BA, PERLMAN TJ et al: A closed sys-tem method for the processing and cryopreservation of porcine hepatocytes for use in a bioartificial liver. J. Cryobio. (1998) (In Press).
  • HEWITT W, ROZGA J, MULLON C, DEMETRIOU A: Bioarti-ficial liver: experimental and clinical experience. In: Ilots de Langerhans et hépatocytes: Vers une utilisation the-rapeutique. Franco D, Boudjema K, Varet B (Eds.), Les Edi-tions INSERM, Paris, France (1998) 9:105–118.
  • CHEN S, MULLON C, KAHAKU E et al.: Treatment of se-vere liver failure with a bioartificial liver. In: Bioartifi-dal Organs, Science, Medicine, and Technology. Prokop A, Hunkeler D, Cherrington D (Eds.), Ann. New York Acad. Sci., New York, USA (1997) 831:350–360.
  • BACH F, FINEBERG HV: Call for moratorium on xeno-transplants. Nature (1998) 391:326.
  • VOGEL G: No moratorium on clinical trials. Science (1998) 279:648.
  • PATIENCE C, PATTON GS, TAKEUCHI Y et al.: No evi-dence of pig DNA or retroviral infection in patients with short-term extracorporeal connection to pig kid-neys. Lancet (1998) 352:699–701.
  • HENEINE W, TIBELL A, SWITZER W et al: No evidence of infection with porcine endogenous retrovirus on re-cipients of porcine islet-cell xenografts. Lancet (1998) 352:695–699.
  • PATIENCE C, TAKEUCHI Y, WEISS R: Infection of humancells by an endogenous virus of pigs. Nature Med. (1997) 3:282–286.
  • FOURNEAU I, DEPLA I, VAN PELT J et al.: Development and characterization of immortalized human hepato-cyte lines and the application in a bioartificial liver de-vice. In: Bioartificial liver support system: The critical issues. Crepaldi G, Demetriou AA, Muraca M (Eds.), CIC Edizioni International, Rome. Italy (1997):104–115.
  • REID L: Stem cell/lineage biology and lineage-dependent extracellular matrix chemistry: keys to tis-sue engineering of quiescent tissues such as liver. In: Principles of Tissue Engineering Lanza R, Chick W, Langer R (Eds.), Springer, R. Langer Co., Austin, Texas, USA (1996) 31 :481–514.
  • ELLIS AJ, HUGHES RD, WILLIAMS R: Bioartificial liver: clinical experience in paracetamol-induced liver fail-ure. In: Ilots de Langerhans et hepatocytes: Vers une utilisa-tion thérapeutique. Franco D, Boudjema K, Varet B (Eds.), Les Editions INSERM, Paris, France (1998) 8:94–104.
  • RIORDAN SM, WILLIAMS R: Experience in design of con-trolled clinical trials in acute liver failure. In: Bioartifi-cial liver support system: the critical issues. Crepaldi G, Demetriou AA, Muraca M (Eds.), CIC Edizioni International, Rome, Italy (1997):104–115.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.